Retrometabolic Drug Design for Developing pharmaceutical Drugs

Xiaoya Zhang

doi:10.4172/2167-065X.1000e125

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial
Clin Pharmacol Biopharm; 2021, Vol 10(10): e-125
DOI: 10.4172/2167-065X.1000e125

Retrometabolic Drug Design for Developing pharmaceutical Drugs

Xiaoya Zhang^*: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, USA

^*Corresponding Author : Xiaoya Zhang, Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, USA, Email: xiaozha@gmail.com

Received Date: Oct 08, 2021 / Accepted Date: Oct 13, 2021 / Published Date: Oct 20, 2021

View PDF Download PDF

Citation: Zhang X (2021) Retro metabolic Drug Design for Developing Pharmaceutical Drugs. Clin Pharmacol Biopharm, 10: e125. Doi: 10.4172/2167-065X.1000e125

Copyright: © 2021 Zhang X. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.